
Sign up to save your podcasts
Or


Ozempic is a drug used to treat type 2 diabetes and obesity but social media influencers have now turned it into the most popular weight loss drug. Promotion of the drug has led to a shortage of supply with Australia's drugs regulator now investigating the matter. However, other issues have contributed to the lack of supply and influencers have promoted weight loss supplements for years. So why is TGA looking into the particular promotion of Ozempic?
In this episode we speak to public health advisor on nutrition, Professor Tim Gill, to find out what’s different about the promotion of this specific drug.
Headlines:
Follow The Briefing:
Instagram: @thebriefingpodcast
Facebook: TheBriefingNewsAU
Twitter: @TheBriefingAU
See omnystudio.com/listener for privacy information.
By LiSTNR3.9
88 ratings
Ozempic is a drug used to treat type 2 diabetes and obesity but social media influencers have now turned it into the most popular weight loss drug. Promotion of the drug has led to a shortage of supply with Australia's drugs regulator now investigating the matter. However, other issues have contributed to the lack of supply and influencers have promoted weight loss supplements for years. So why is TGA looking into the particular promotion of Ozempic?
In this episode we speak to public health advisor on nutrition, Professor Tim Gill, to find out what’s different about the promotion of this specific drug.
Headlines:
Follow The Briefing:
Instagram: @thebriefingpodcast
Facebook: TheBriefingNewsAU
Twitter: @TheBriefingAU
See omnystudio.com/listener for privacy information.

45 Listeners

787 Listeners

95 Listeners

183 Listeners

368 Listeners

4 Listeners

331 Listeners

18 Listeners

48 Listeners

144 Listeners

77 Listeners

3 Listeners

98 Listeners

114 Listeners

321 Listeners

147 Listeners

155 Listeners

0 Listeners

15 Listeners

0 Listeners

23 Listeners

8 Listeners

254 Listeners

18 Listeners

6 Listeners

101 Listeners

41 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

28 Listeners